Although the first human Ron mAb IMC-41A10 was not reported to downmodulate Ron expression, our studies found that IMC-RON8 treatment promoted Ron degradation in pancreatic cancer cells. The gene discussed is MST1R; the disease is familial pancreatic carcinoma.